CAP37 activation of PKC promotes human corneal epithelial cell Chemotaxis

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 10, 2013, Pages 6712-6723

  Griffith, Gina L ^a   Russell, Robert A ^b   Kasus Jacobi, Anne ^b,c   Thavathiru, Elangovan ^a   Gonzalez, Melva L ^a   Logan, Sreemathi ^a   Pereira, H Anne ^a,b,c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c Oklahoma Center for Neuroscience   (United States)

Author keywords

Cationic antimicrobial proteins; Inflammation; Migration; Protein kinase C; Signaling

Indexed keywords

CALPHOSTIN C; CATIONIC ANTIMICROBIAL PROTEIN OF 37; PEPTIDES AND PROTEINS; PERTUSSIS TOXIN; PHORBOL ESTER; PROTEIN KINASE C; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; CARRIER PROTEIN; CATIONIC ANTIMICROBIAL PROTEIN CAP 37, HUMAN; GLYCOPROTEIN; PLASMA PROTEIN; CATHEPSIN G; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTOXIN; G PROTEIN COUPLED RECEPTOR; LEUKOCYTE ELASTASE; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA EPITHELIUM; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CATIONIC ANTIMICROBIAL PROTEINS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; METABOLISM; MIGRATION; PHYSIOLOGY; SIGNALING; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; KERATINOCYTE; PROTEIN BLOOD LEVEL; SEQUENCE HOMOLOGY;

CATIONIC ANTIMICROBIAL PROTEINS; INFLAMMATION; MIGRATION; PROTEIN KINASE C; SIGNALING;

ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; BLOTTING, WESTERN; CARRIER PROTEINS; CELLS, CULTURED; CHEMOTAXIS; ENZYME ACTIVATION; EPITHELIUM, CORNEAL; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; PROTEIN KINASE C; SIGNAL TRANSDUCTION;

EID: 84885617647     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12054     Document Type: Article

References (49)

1. Kay RR, Langridge P, Traynor D, Hoeller O. Changing directions in the study of chemotaxis. Nature Rev Mol Cell Biol. 2008;9:455-463.
2. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. Neutrophil function: from mechanisms to disease. Annu Rev Immunol. 2012;30:459-489.
3. Pereira HA, Shafer WM, Pohl J, Martin LE, Spitznagel JK. CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J Clin Invest. 1990;85:1468-1476.
4. Pereira HA. CAP37, a neutrophil-derived multifunctional inflammatory mediator. J Leukoc Biol. 1995;57:805-812.
5. Pereira HA, Ruan X, Gonzalez ML, Tsyshevskaya-Hoover I, Chodosh J. Modulation of corneal epithelial cell functions by the neutrophil-derived inflammatory mediator CAP37. Invest Ophthalmol Vis Sci. 2004;45:4284-4292.
6. Lee TD, Gonzalez ML, Kumar P, Grammas P, Pereira HA. CAP37, a neutrophil-derived inflammatory mediator, augments leukocyte adhesion to endothelial monolayers. Microvasc Res. 2003;66:38-48.
7. Lee TD, Gonzalez ML, Kumar P, Chary-Reddy S, Grammas P, Pereira HA. CAP37, a novel inflammatory mediator: its expression in endothelial cells and localization to atherosclerotic lesions. Am J Pathol. 2002;160:841-848.
8. Ruan X, Chodosh J, Callegan MC, et al. Corneal expression of the inflammatory mediator CAP37. Invest Ophthalmol Vis Sci. 2002;43:1414-1421.
9. Pereira HA, Ruan X, Kumar P. Activation of microglia: a neuroinflammatory role for CAP37. Glia. 2003;41:64-72.
10. Morgan JG, Pereira HA, Sukiennicki T, Spitznagel JK, Larrick JW. Human neutrophil granule cationic protein CAP37 is a specific macrophage chemotaxin that shares homology with inflammatory proteinases. Adv Exp Med Biol. 1991;305:89-96.
11. Gonzalez ML, Ruan X, Kumar P, Grammas P, Pereira HA. Functional modulation of smooth muscle cells by the inflammatory mediator CAP37. Microvasc Res. 2004;67:168-181.
12. Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. 2000;19:113-129.
13. Pereira HA, Moore P, Grammas P. CAP37, a neutrophil granule-derived protein stimulates protein kinase C activity in endothelial cells. J Leukoc Biol. 1996;60:415-422.
14. Steinberg SF. Structural basis of protein kinase C isoform function. Physiol Rev. 2008;88:1341-1378.
15. O'Connell MJ, Raleigh JM, Verkade HM, Nurse P. Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J. 1997;16:545-554.
16. Dempsey EC, Newton AC, Mochly-Rosen D, et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol. 2000;279:L429-438.
17. Suzuki K, Saito J, Yanai R, et al. Cell-matrix and cell-cell interactions during corneal epithelial wound healing. Prog Retin Eye Res. 2003;22:113-133.
18. Newton AC. Lipid activation of protein kinases. J Lipid Res. 2009;50:S266-S271.
19. Araki-Sasaki K, Ohashi Y, Sasabe T, et al. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci. 1995;36:614-621.
20. Li Y, Santos CM, Kumar A, et al. "Click" immobilization on alkylated silicon substrates: model for the study of surface bound antimicrobial peptides. Chemistry. 2011;17:2656-2665.
21. Rezaie AR, Esmon CT. The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin complex can be distinguished by mutational analysis of protein C derivatives. J Biol Chem. 1992;267:26104-26109.
22. Rezaie AR, Neuenschwander PF, Morrissey JH, Esmon CT. Analysis of the functions of the first epidermal growth factor-like domain of factor X. J Biol Chem. 1993;268:8176-8180.
23. Pereira HA. Assay systems for measurement of chemotactic activity. Methods Mol Biol. 1997;78:233-246.
24. Niemann MA, Bhown AS, Bennett JC, Volanakis JE. Amino acid sequence of human D of the alternative complement pathway. Biochemistry. 1984;23:2482-2486.
25. Tamura M, Nogimori K, Murai S, et al. Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. Biochemistry. 1982;21:5516-5522.
26. Carbonetti NH. Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools. Future Microbiol. 2010;5:455-469.
27. Piiper A, Gebhardt R, Kronenberger B, Giannini CD, Elez R, Zeuzem S. Pertussis toxin inhibits cholecystokinin-and epidermal growth factor-induced mitogen-activated protein kinase activation by disinhibition of the cAMP signaling pathway and inhibition of c-Raf-1. Mol Pharmacol. 2000;58: 608-613.
28. Yang LJ, Baffy G, Rhee SG, Manning D, Hansen CA, Williamson JR. Pertussis toxin-sensitive Gi protein involvement in epidermal growth factor-induced activation of phospholipase C-gamma in rat hepatocytes. J Biol Chem. 1991;266:22451-22458.
29. Liang MN, Garrison JC. The epidermal growth factor receptor is coupled to a pertussis toxin-sensitive guanine nucleotide regulatory protein in rat hepatocytes. J Biol Chem. 1991;266: 13342-13349.
30. Le Stunff H, Mikami A, Giussani P, et al. Role of sphingosine-1-phosphate phosphatase 1 in epidermal growth factor-induced chemotaxis. J Biol Chem. 2004;279:34290-34297.
31. Ramachandran R, Mihara K, Chung H, et al. Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2). J Biol Chem. 2011;286:24638-24648.
32. Sun R, Iribarren P, Zhang N, et al. Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor. J Immunol. 2004;173:428-436.
33. Vilardaga JP, Agnati LF, Fuxe K, Ciruela F. G-protein-coupled receptor heteromer dynamics. J Cell Sci. 2010;123:4215-4220.
34. Lappano R, Maggiolini M. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov. 2011;10:47-60.
35. Ronnstrand L, Heldin CH. Mechanisms of platelet-derived growth factor-induced chemotaxis. Int J Cancer. 2001;91:757-762.
36. Xu KP, Dartt DA, Yu FS. EGF-induced ERK phosphorylation independent of PKC isozymes in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2002;43:3673-3679.
37. Vorotnikov AV. Chemotaxis: movement, direction, control. Biochemistry Biokhimiia. 2011;76:1528-1555.
38. Sun L, Ye RD. Role of G protein-coupled receptors in inflammation. Acta Pharmacol Sin. 2012;33:342-350.
39. Horovitz-Fried M, Cooper DR, Patel NA, et al. Insulin rapidly upregulates protein kinase C delta gene expression in skeletal muscle. Cell Signal. 2006;18:183-193.
40. Kurkinen KM, Keinanen RA, Karhu R, Koistinaho J. Genomic structure and chromosomal localization of the rat protein kinase Cdelta-gene. Gene. 2000;242:115-123.
41. Suh KS, Tatunchak TT, Crutchley JM, Edwards LE, Marin KG, Yuspa SH. Genomic structure and promoter analysis of PKC-delta. Genomics. 2003;82:57-67.
42. Cowen DS, Molinoff PB, Manning DR. 5-hydroxytryptamine1A receptor-mediated increases in receptor expression and activation of nuclear factor-kappaB in transfected Chinese hamster ovary cells. Mol Pharmacol. 1997;52:221-226.
43. Yang M, Sang H, Rahman A, Wu D, Malik AB, Ye RD. G alpha 16 couples chemoattractant receptors to NF-kappa B activation. J Immunol. 2001;166:6885-6892.
44. Newton AC. Protein kinase C: structure, function, and regulation. J Biol Chem. 1995;270:28495-28498.
45. Murugappan S, Tuluc F, Dorsam RT, Shankar H, Kunapuli SP. Differential role of protein kinase C delta isoform in agonist-induced dense granule secretion in human platelets. J Biol Chem. 2004;279:2360-2367.
46. Liu Y, Belkina NV, Graham C, Shaw S. Independence of protein kinase C-delta activity from activation loop phosphorylation: structural basis and altered functions in cells. J Biol Chem. 2006;281:12102-12111.
47. Basu A, Pal D. Two faces of protein kinase Cdelta: the contrasting roles of PKCdelta in cell survival and cell death. ScientificWorldJournal. 2010;10:2272-2284.
48. Ciccocioppo F, Lanuti P, Marchisio M, et al. Expression and phosphorylation of protein kinase C isoforms in Abeta (1-42) activated T lymphocytes from Alzheimers disease. Int J Immunopathol Pharmacol. 2008;21:23-33.
49. Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res. 2010;106: 1319-1331.